DOCUMENT METADATA

Document ID

DOC-CK-009

Version

1.0

Status

LOCKED

Authority

Clinical Knowledge Governance

Owner

Project Coordinator

Strategist

ChatGPT

Implementation

Claude

Depends On

EVIDENCE_PACKAGE_SPECIFICATION.md
CLINICAL_KNOWLEDGE_POPULATION_STRATEGY.md
KNOWLEDGE_SOURCE_REGISTRY.md
KNOWLEDGE_SOURCE_APPROVAL_POLICY.md
KNOWLEDGE_UPDATE_POLICY.md

Required By

All Evidence Packages
Clinical Knowledge Objects
Knowledge Passports
Governance Review

Last Updated

2026-08-03

1. PURPOSE

This document defines the standardized operational process for constructing, validating, maintaining, and updating Evidence Packages within the Safe Medical AI System.

Evidence Packages constitute the governed evidence foundation supporting every Clinical Knowledge Object.

2. DESIGN PHILOSOPHY

Evidence Package population follows:

Evidence before Recommendation
Governance before Publication
Traceability by Design
Hierarchical Evidence Integration
Amendment-first Evolution
Continuous Evidence Currency

Evidence Packages represent curated evidence assets rather than literature collections.

3. ROLE

This document governs:

Evidence Package construction;
evidence source integration;
evidence hierarchy;
operational population workflow;
evidence lifecycle management.

It does not define:

clinical recommendations;
patient education narratives;
runtime reasoning;
retrieval behavior.
4. EVIDENCE PACKAGE OWNERSHIP

Every Clinical Knowledge Object shall possess one Primary Evidence Package.

An Evidence Package governs the evidence supporting a single Clinical Knowledge Object.

Individual evidence sources may contribute to multiple Evidence Packages; however, each Evidence Package shall maintain its own governed synthesis and traceability.

5. EVIDENCE COMPOSITION

Evidence Packages shall contain curated evidence assembled from approved knowledge sources.

Evidence may include:

clinical practice guidelines;
consensus statements;
systematic reviews;
meta-analyses;
randomized controlled trials;
observational studies;
other approved evidence sources defined by the Knowledge Source Registry.

Evidence shall be curated, synthesized, and organized according to governance standards rather than copied verbatim.

6. EVIDENCE HIERARCHY

Evidence shall be organized according to the approved governance hierarchy.

Typical prioritization includes:

Level 1

Clinical Practice Guidelines

↓

Level 2

Systematic Reviews and Meta-analyses

↓

Level 3

Randomized Controlled Trials

↓

Level 4

Observational Studies

↓

Level 5

Other Approved Sources

Higher-level evidence shall take precedence during evidence synthesis while preserving visibility of supporting lower-level evidence when appropriate.

7. POPULATION WORKFLOW

Evidence Package construction follows the standardized workflow:

Approved Source Identification

↓

Source Eligibility Assessment

↓

Evidence Extraction

↓

Evidence Synthesis

↓

Evidence Package Assembly

↓

Governance Validation

↓

Linkage to Clinical Knowledge Object

↓

Knowledge Passport Synchronization

↓

Repository Integration

Each stage shall maintain explicit provenance and governance traceability.

8. UPDATE STRATEGY

Evidence Packages are governed living assets.

Updates may be initiated by:

newly approved clinical guidelines;
newly published high-level evidence;
governance review outcomes;
scheduled evidence maintenance;
safety-related updates.

Whenever an Evidence Package is amended, downstream review shall determine whether updates to the linked Clinical Knowledge Object and Knowledge Passport are required.

9. GOVERNANCE PRINCIPLES

Every Evidence Package shall maintain:

explicit evidence provenance;
approved source eligibility;
transparent evidence hierarchy;
reproducible synthesis;
complete traceability;
governance approval.

Evidence Packages function as the authoritative evidence record supporting Clinical Knowledge Objects.

10. QUALITY REQUIREMENTS

Before approval, every Evidence Package shall satisfy:

approved evidence sources;
complete provenance documentation;
evidence hierarchy compliance;
synthesis completeness;
governance validation;
linkage verification;
update traceability.

Only validated Evidence Packages may support Active Clinical Knowledge Objects.

11. RELATED DOCUMENTS
Upstream
EVIDENCE_PACKAGE_SPECIFICATION.md
CLINICAL_KNOWLEDGE_POPULATION_STRATEGY.md
KNOWLEDGE_SOURCE_REGISTRY.md
KNOWLEDGE_SOURCE_APPROVAL_POLICY.md
KNOWLEDGE_UPDATE_POLICY.md
Downstream
Clinical Knowledge Objects
Knowledge Passports
Clinical Validation Records
Retrieval-ready Knowledge Repository
12. AMENDMENT TRACEABILITY
Version 1.0

Initial Phase 3 release.

Integrated Locked Decisions:

LD-0396 — Evidence Package Ownership
LD-0397 — Evidence Composition
LD-0398 — Evidence Hierarchy
LD-0399 — Evidence Population Workflow
LD-0400 — Evidence Update Strategy

This document establishes the operational governance guide for all Evidence Packages and standardizes the construction, validation, maintenance, and synchronization of evidence assets throughout the knowledge population lifecycle.